Inventiva S.A. (EPA:IVA)
2.770
+0.045 (1.65%)
Apr 1, 2025, 10:43 AM CET
Inventiva Employees
As of December 31, 2023, Inventiva had 123 total employees, including 120 full-time and 3 part-time employees. The number of employees increased by 10 or 8.85% compared to the previous year.
Employees
123
Change (1Y)
10
Growth (1Y)
8.85%
Revenue / Employee
€119,707
Profits / Employee
€1,497,659
Market Cap
260.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 82,878 |
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 13,982 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 5,459 |
emeis Société anonyme | 77,954 |
Inventiva News
- 4 days ago - Inventiva S.A. (IVA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Inventiva reports its 2024 full year results and provides a business update - GlobeNewsWire
- 12 days ago - Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results - GlobeNewsWire
- 4 weeks ago - Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment - GlobeNewsWire
- 5 weeks ago - Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial - GlobeNewsWire
- 7 weeks ago - Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update - GlobeNewsWire
- 2 months ago - Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology - GlobeNewsWire
- 2 months ago - Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux - GlobeNewsWire